Evaxion Biotech A/S, a clinical-stage biotech company, engages in developing artificial intelligence-powered immunotherapies for cancers, bacterial diseases, and viral infections. The company develops EVX-01, a cancer immunotherapy that is in clinical Phase IIb trial for metastatic melanoma; EVX-02, a DNA-based cancer immunotherapy that is in Phase IIa trial for adjuvant melanoma; and EVX-03, a DNA-based immunotherapy for the treatment of various cancers. Its programs also include EVX-B1, EVX-B2, and EVX-V1, which are vaccines that are in pre-clinical stage for the treatment of bacterial and viral diseases. The company was incorporated in 2008 and is headquartered in Hørsholm, Denmark.

Evaxion Biotech A/S

We are a clinical-stage AI-immunology™ platform company using our proprietary artificial intelligence, or AI, technology, engineering expertise and drug development know-how to simulate the human immune system and generate predictive models to identify and develop novel immunotherapies for the treatment of various cancers, bacterial diseases and viral infections. 
We are currently in the clinic with our two lead product candidates, EVX-01 and EVX-02, for the treatment of various cancers.

We have four proprietary AI prediction models: PIONEER, ObsERV, EDEN and RAVEN.

Filer	Shares	Latest Filing Date	Change	Share-Type	Market Value
Maven Securities Ltd	230.61K	2021-05-17	230.61K	Shares	1.27M
Granite Point Capital Manag...	224.60K	2021-05-12	224.60K	Shares	1.32M
Luminus Management Llc	194.93K	2021-05-17	194.93K	Shares	1.15M
Alyeska Investment Group, L.P.	86.73K	2021-05-17	86.73K	Shares	512K
Telemetry Investments, L.L.C.	73.85K	2021-05-17	73.85K	Shares	436K
Kepos Capital Lp	37.10K	2021-05-13	37.10K	Shares	219K
Altium Capital Management Lp	24.73K	2021-05-06	24.73K	Shares	146K
Etf Managers Group, Llc	5.92K	2021-05-17	5.92K	Shares	31K
Advisor Group Holdings, Inc.	5.43K	2021-05-13	5.43K	Shares	32K
Morgan Stanley	100	2021-05-17	100	Shares	1K
Concourse Financial Group S...	0	2021-05-13	0	Shares	0

NASDAQ:EVAX

Evaxion Biotech A/S

Last Close

2.91

26/07 20:00

Market Cap

16.59M

Beta: 0.56

Volume Today

11.28K

Avg: 118.15K

PE Ratio

−0.47

PFCF: 6.47

Institutional trades

Institutional Ownership

Current holdings institutionals